August 07, 2013
A Texas federal judge ruled Tuesday that Accuhale LLC's suit alleging AstraZeneca LP infringed a patent for a pressurized metered-dose inhaler indicator could move forward, saying AstraZeneca hadn't proven that the patent was indefinite and invalid.
January 03, 2012
Texas-based Accuhale LLC hit AstraZeneca PLC with a patent infringement suit Thursday, claiming the pharmaceutical giant violated federal law with its Symbicort pressurized metered-dose inhaler for the management of asthma and chronic obstructive pulmonary disease.